Anti-Cancer Peptide Vaccines And Inhibitors Developed

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort, according to two studies published in  OncoImmunology.  Researchers from  at The Ohio State University Comprehensive Cancer Center identify new peptide vaccines and inhibitors that target the HER-3 and IGF-1R receptors. All four agents elicited significant anti-tumor responses in human cancer cell lines and in animal models.  read more

Read the whole article on

More from